Cite
HARVARD Citation
Choi, C. et al. (2020). Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome. British journal of haematology. pp. e68-e72. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Choi, C. et al. (2020). Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome. British journal of haematology. pp. e68-e72. [Online].